- IBDEI378 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,51075,1,3,0)
- ;;=3^Cirrhosis of Liver,Oth
- ;;^UTILITY(U,$J,358.3,51075,1,4,0)
- ;;=4^K74.69
- ;;^UTILITY(U,$J,358.3,51075,2)
- ;;=^5008823
- ;;^UTILITY(U,$J,358.3,51076,0)
- ;;=K74.60^^193^2500^11
- ;;^UTILITY(U,$J,358.3,51076,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51076,1,3,0)
- ;;=3^Cirrhosis of Liver,Unspec
- ;;^UTILITY(U,$J,358.3,51076,1,4,0)
- ;;=4^K74.60
- ;;^UTILITY(U,$J,358.3,51076,2)
- ;;=^5008822
- ;;^UTILITY(U,$J,358.3,51077,0)
- ;;=K76.0^^193^2500^12
- ;;^UTILITY(U,$J,358.3,51077,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51077,1,3,0)
- ;;=3^Fatty Liver NEC
- ;;^UTILITY(U,$J,358.3,51077,1,4,0)
- ;;=4^K76.0
- ;;^UTILITY(U,$J,358.3,51077,2)
- ;;=^5008831
- ;;^UTILITY(U,$J,358.3,51078,0)
- ;;=K76.89^^193^2500^18
- ;;^UTILITY(U,$J,358.3,51078,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51078,1,3,0)
- ;;=3^Liver Disease NEC
- ;;^UTILITY(U,$J,358.3,51078,1,4,0)
- ;;=4^K76.89
- ;;^UTILITY(U,$J,358.3,51078,2)
- ;;=^5008835
- ;;^UTILITY(U,$J,358.3,51079,0)
- ;;=K71.6^^193^2500^32
- ;;^UTILITY(U,$J,358.3,51079,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51079,1,3,0)
- ;;=3^Toxic Liver Disease w/ Hepatitis NEC
- ;;^UTILITY(U,$J,358.3,51079,1,4,0)
- ;;=4^K71.6
- ;;^UTILITY(U,$J,358.3,51079,2)
- ;;=^5008801
- ;;^UTILITY(U,$J,358.3,51080,0)
- ;;=K75.9^^193^2500^17
- ;;^UTILITY(U,$J,358.3,51080,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51080,1,3,0)
- ;;=3^Inflammatory Liver Disease,Unspec
- ;;^UTILITY(U,$J,358.3,51080,1,4,0)
- ;;=4^K75.9
- ;;^UTILITY(U,$J,358.3,51080,2)
- ;;=^5008830
- ;;^UTILITY(U,$J,358.3,51081,0)
- ;;=K71.0^^193^2500^24
- ;;^UTILITY(U,$J,358.3,51081,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51081,1,3,0)
- ;;=3^Toxic Liver Disease w/ Cholestasis
- ;;^UTILITY(U,$J,358.3,51081,1,4,0)
- ;;=4^K71.0
- ;;^UTILITY(U,$J,358.3,51081,2)
- ;;=^5008793
- ;;^UTILITY(U,$J,358.3,51082,0)
- ;;=K71.10^^193^2500^30
- ;;^UTILITY(U,$J,358.3,51082,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51082,1,3,0)
- ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
- ;;^UTILITY(U,$J,358.3,51082,1,4,0)
- ;;=4^K71.10
- ;;^UTILITY(U,$J,358.3,51082,2)
- ;;=^5008794
- ;;^UTILITY(U,$J,358.3,51083,0)
- ;;=K71.11^^193^2500^31
- ;;^UTILITY(U,$J,358.3,51083,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51083,1,3,0)
- ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
- ;;^UTILITY(U,$J,358.3,51083,1,4,0)
- ;;=4^K71.11
- ;;^UTILITY(U,$J,358.3,51083,2)
- ;;=^5008795
- ;;^UTILITY(U,$J,358.3,51084,0)
- ;;=K71.2^^193^2500^23
- ;;^UTILITY(U,$J,358.3,51084,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51084,1,3,0)
- ;;=3^Toxic Liver Disease w/ Acute Hepatitis
- ;;^UTILITY(U,$J,358.3,51084,1,4,0)
- ;;=4^K71.2
- ;;^UTILITY(U,$J,358.3,51084,2)
- ;;=^5008796
- ;;^UTILITY(U,$J,358.3,51085,0)
- ;;=K71.3^^193^2500^28
- ;;^UTILITY(U,$J,358.3,51085,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51085,1,3,0)
- ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
- ;;^UTILITY(U,$J,358.3,51085,1,4,0)
- ;;=4^K71.3
- ;;^UTILITY(U,$J,358.3,51085,2)
- ;;=^5008797
- ;;^UTILITY(U,$J,358.3,51086,0)
- ;;=K71.4^^193^2500^27
- ;;^UTILITY(U,$J,358.3,51086,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51086,1,3,0)
- ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
- ;;^UTILITY(U,$J,358.3,51086,1,4,0)
- ;;=4^K71.4
- ;;^UTILITY(U,$J,358.3,51086,2)
- ;;=^5008798
- ;;^UTILITY(U,$J,358.3,51087,0)
- ;;=K75.81^^193^2500^19
- ;;^UTILITY(U,$J,358.3,51087,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,51087,1,3,0)
- ;;=3^Nonalcoholic Steatohepatitis (NASH)
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI378 3796 printed Feb 19, 2025@00:09:35 Page 2
- IBDEI378 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,51075,1,3,0)
- +2 ;;=3^Cirrhosis of Liver,Oth
- +3 ;;^UTILITY(U,$J,358.3,51075,1,4,0)
- +4 ;;=4^K74.69
- +5 ;;^UTILITY(U,$J,358.3,51075,2)
- +6 ;;=^5008823
- +7 ;;^UTILITY(U,$J,358.3,51076,0)
- +8 ;;=K74.60^^193^2500^11
- +9 ;;^UTILITY(U,$J,358.3,51076,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,51076,1,3,0)
- +12 ;;=3^Cirrhosis of Liver,Unspec
- +13 ;;^UTILITY(U,$J,358.3,51076,1,4,0)
- +14 ;;=4^K74.60
- +15 ;;^UTILITY(U,$J,358.3,51076,2)
- +16 ;;=^5008822
- +17 ;;^UTILITY(U,$J,358.3,51077,0)
- +18 ;;=K76.0^^193^2500^12
- +19 ;;^UTILITY(U,$J,358.3,51077,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,51077,1,3,0)
- +22 ;;=3^Fatty Liver NEC
- +23 ;;^UTILITY(U,$J,358.3,51077,1,4,0)
- +24 ;;=4^K76.0
- +25 ;;^UTILITY(U,$J,358.3,51077,2)
- +26 ;;=^5008831
- +27 ;;^UTILITY(U,$J,358.3,51078,0)
- +28 ;;=K76.89^^193^2500^18
- +29 ;;^UTILITY(U,$J,358.3,51078,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,51078,1,3,0)
- +32 ;;=3^Liver Disease NEC
- +33 ;;^UTILITY(U,$J,358.3,51078,1,4,0)
- +34 ;;=4^K76.89
- +35 ;;^UTILITY(U,$J,358.3,51078,2)
- +36 ;;=^5008835
- +37 ;;^UTILITY(U,$J,358.3,51079,0)
- +38 ;;=K71.6^^193^2500^32
- +39 ;;^UTILITY(U,$J,358.3,51079,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,51079,1,3,0)
- +42 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
- +43 ;;^UTILITY(U,$J,358.3,51079,1,4,0)
- +44 ;;=4^K71.6
- +45 ;;^UTILITY(U,$J,358.3,51079,2)
- +46 ;;=^5008801
- +47 ;;^UTILITY(U,$J,358.3,51080,0)
- +48 ;;=K75.9^^193^2500^17
- +49 ;;^UTILITY(U,$J,358.3,51080,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,51080,1,3,0)
- +52 ;;=3^Inflammatory Liver Disease,Unspec
- +53 ;;^UTILITY(U,$J,358.3,51080,1,4,0)
- +54 ;;=4^K75.9
- +55 ;;^UTILITY(U,$J,358.3,51080,2)
- +56 ;;=^5008830
- +57 ;;^UTILITY(U,$J,358.3,51081,0)
- +58 ;;=K71.0^^193^2500^24
- +59 ;;^UTILITY(U,$J,358.3,51081,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,51081,1,3,0)
- +62 ;;=3^Toxic Liver Disease w/ Cholestasis
- +63 ;;^UTILITY(U,$J,358.3,51081,1,4,0)
- +64 ;;=4^K71.0
- +65 ;;^UTILITY(U,$J,358.3,51081,2)
- +66 ;;=^5008793
- +67 ;;^UTILITY(U,$J,358.3,51082,0)
- +68 ;;=K71.10^^193^2500^30
- +69 ;;^UTILITY(U,$J,358.3,51082,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,51082,1,3,0)
- +72 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
- +73 ;;^UTILITY(U,$J,358.3,51082,1,4,0)
- +74 ;;=4^K71.10
- +75 ;;^UTILITY(U,$J,358.3,51082,2)
- +76 ;;=^5008794
- +77 ;;^UTILITY(U,$J,358.3,51083,0)
- +78 ;;=K71.11^^193^2500^31
- +79 ;;^UTILITY(U,$J,358.3,51083,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,51083,1,3,0)
- +82 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
- +83 ;;^UTILITY(U,$J,358.3,51083,1,4,0)
- +84 ;;=4^K71.11
- +85 ;;^UTILITY(U,$J,358.3,51083,2)
- +86 ;;=^5008795
- +87 ;;^UTILITY(U,$J,358.3,51084,0)
- +88 ;;=K71.2^^193^2500^23
- +89 ;;^UTILITY(U,$J,358.3,51084,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,51084,1,3,0)
- +92 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
- +93 ;;^UTILITY(U,$J,358.3,51084,1,4,0)
- +94 ;;=4^K71.2
- +95 ;;^UTILITY(U,$J,358.3,51084,2)
- +96 ;;=^5008796
- +97 ;;^UTILITY(U,$J,358.3,51085,0)
- +98 ;;=K71.3^^193^2500^28
- +99 ;;^UTILITY(U,$J,358.3,51085,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,51085,1,3,0)
- +102 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
- +103 ;;^UTILITY(U,$J,358.3,51085,1,4,0)
- +104 ;;=4^K71.3
- +105 ;;^UTILITY(U,$J,358.3,51085,2)
- +106 ;;=^5008797
- +107 ;;^UTILITY(U,$J,358.3,51086,0)
- +108 ;;=K71.4^^193^2500^27
- +109 ;;^UTILITY(U,$J,358.3,51086,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,51086,1,3,0)
- +112 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
- +113 ;;^UTILITY(U,$J,358.3,51086,1,4,0)
- +114 ;;=4^K71.4
- +115 ;;^UTILITY(U,$J,358.3,51086,2)
- +116 ;;=^5008798
- +117 ;;^UTILITY(U,$J,358.3,51087,0)
- +118 ;;=K75.81^^193^2500^19
- +119 ;;^UTILITY(U,$J,358.3,51087,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,51087,1,3,0)
- +122 ;;=3^Nonalcoholic Steatohepatitis (NASH)